BIOMEDICAL DIAGNOSTICS
ActiveSummary
BIOMEDICAL DIAGNOSTICS has been active since 2003 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.5m and a net result of €339,858. Equity is growing by about 18% per year across the filed financial years. Its solvency ranks better than 76% of 6,075 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
19-06
NBB filing
Annual accounts filed
financial year 2025 · full format
2025
26-11
Gazette deed
Appointment: Van Havermaet Bedrijfsrevisoren BV (statutory auditor)2 facts ▸
Gazette deed
Appointment: Van Havermaet Bedrijfsrevisoren BV (statutory auditor)
2 facts ▸
- General meeting, 17-06-2025
- Auditor appointment, Van Havermaet Bedrijfsrevisoren BV (statutory auditor)
24-06
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format
02-05
Gazette deed
Resignation: NV Eurobio Scientific Benelux (director)Permanent representatives: Hervé Duchesne De Lamotte and Dries Renders · Appointment: Olivier Bosc (director) · Director discharge8 facts ▸
Gazette deed
Resignation: NV Eurobio Scientific Benelux (director)
Permanent representatives: Hervé Duchesne De Lamotte and Dries Renders · Appointment: Olivier Bosc (director) · Director discharge8 facts ▸
- General meeting, 27-02-2025
- Director resignation, NV Eurobio Scientific Benelux (director (not named in the articles))
- Director discharge, NV Eurobio Scientific Benelux
- Permanent representative, Hervé Duchesne De Lamotte (vaste vertegenwoordiger belast met de uitvoering van bestuursmandaat in naam en voor rekening van de rechtspersoon)
- Other provision, “kennisname en akkoord met ontslag vaste vertegenwoordiger” (deed in Dutch)
- Director appointment, Olivier Bosc (director (not named in the articles))
- Permanent representative, Dries Renders
- Director in office, Kantoor Renders BV (director)
2024
31-12
Financial
Equity above €2mequity €2.1m ▲21.6%
A profit in every financial year since 2018 builds equity to €2.1m.
22-10
Gazette deed
Permanent representative: Fabienne STEENSAppointment: STEENS MANAGEMENT (managing director)3 facts ▸
Gazette deed
Permanent representative: Fabienne STEENS
Appointment: STEENS MANAGEMENT (managing director)3 facts ▸
- Board meeting, 13-08-2024
- Permanent representative, Fabienne STEENS
- Director appointment, STEENS MANAGEMENT (managing director)
03-07
Gazette deed
RestructuringPermanent representatives: Fabienne Steens and Denis Fortier · Merger · Shareholding17 facts ▸
Gazette deed
Restructuring
Permanent representatives: Fabienne Steens and Denis Fortier · Merger · Shareholding17 facts ▸
- Merger, “fusie door overneming met vereenvoudigde procedure, ter goedkeuring aan respectieve algemene vergaderingen van aandeelhouders” (deed in Dutch)
- Other provision, “BE-479.414.976, Ahlers House,Noorderlaan 139-3de verdieping,2030 Antwerpen” (deed in Dutch)
- Other provision, 15-01-2003
- Director in office, BV Steens Management (director)
- Permanent representative, Fabienne Steens
- Other provision, 04-11-1983
- Director in office, Eurobio Scientific SA (director)
- Permanent representative, Denis Fortier
- Shareholding, Eurobio Scientific Benelux
- Accounting effect, 01-01-2024
- Other provision, “geen nieuwe aandelen en geen ruilverhouding, gehele vermogen van NV Eurobio Scientific Benelux op NV Biomedical Diagnostics” (deed in Dutch)
- Other provision, “bijzondere rechten” (deed in Dutch)
- +5 further facts in this act
19-06
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format
15-04
Gazette deed
Appointment: Van Havermaet Bedrijfsrevisoren BV (statutory auditor)Permanent representative: Adriaan Ernon3 facts ▸
Gazette deed
Appointment: Van Havermaet Bedrijfsrevisoren BV (statutory auditor)
Permanent representative: Adriaan Ernon3 facts ▸
- General meeting, 02-02-2023
- Auditor appointment, Van Havermaet Bedrijfsrevisoren BV (statutory auditor)
- Permanent representative, Adriaan Ernon
2023
26-06
NBB filing
Annual accounts filed
financial year 2022 · abbreviated format
2022
31-12
Financial
Liquidity more than doubledcurrent ratio 3.18
Current ratio from 1.50 to 3.18; short-term debt falls from €1.1m to €480,454.
31-12
Financial
Equity above €1mequity €1.1m ▲106%
A profit in every financial year since 2018 builds equity to €1.1m.
Show earlier events
30-06
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format
2021
23-07
NBB filing
Annual accounts filed
financial year 2020 · abbreviated format
2020
09-07
NBB filing
Annual accounts filed
financial year 2019 · abbreviated format
2019
31-07
NBB filing
Annual accounts filed
financial year 2018 · abbreviated format
2018
16-07
NBB filing
Annual accounts filed
financial year 2017 · abbreviated format
2017
14-07
NBB filing
Annual accounts filed
financial year 2016 · abbreviated format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 22 annual accounts filed, the latest 10 are here; all 22 are under Financials.
5 of 13 deeds read
About the unread acts
Of the 13 Belgian Official Gazette deeds we know for this company, 5 have been read. The other 8 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.